HAIR LOSS TREATMENT MARKET ANALYSIS
Global Hair Loss Treatment Market: Key Developments
In September 2021, Dr. Reddy's Laboratories, a India-based multinational pharmaceutical company, launched prescription drug Minoxidil topical solution USP (U.S. Pharmacopeia) 2 % and 5 % for the treatment of female pattern hair loss in India. The company launched minoxidil topical solution under the brand name of Mintop 2 per cent and Mintop Eva 5 per cent, respectively.
On June 26, 2023, the U.S. Food and Drug Administration (FDA), announced that it had approved Ritlecitinib, a kinase inhibitor that inhibits Janus kinase 3 and tyrosine kinase for treatment of alopecia areata in individual of age 12 years and above.
In June 2021, Eli Lilly and Company, an U.S.-based multinational pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved OLUMIANT (baricitinib), a once-daily pill, as a first-in-disease systemic treatment for adults with severe alopecia areata (AA), available as 4-mg, 2-mg and 1-mg tablets.
Hair Loss Treatment Market Report Snapshots
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :